An Orléans bioscience firm that’s working on cannabinoid-based drugs designed to mimic the anti-inflammatory benefits of cannabis without the side effects has closed a $10-million public offering to help fund its research.
Tetra Bio-Pharma said Monday it sold a total of 25 million units in the company for 40 cents each. Each unit consists of one share in Tetra as well as a warrant that entitles the buyer to purchase an additional share within the next 24 months at a price of 51 cents.
The offering was led by Echelon Wealth Partners, with additional participation from Canaccord Genuity and Leede Jones Gable.
High Tide Inc. (TSXV:HITI) (OTCQB:HITIF) (FRA: 2LY) will raise $15 million via a bought deal public offering with ATB Capital Markets and Echelon Wealth Partners Inc. on behalf of a group of underwriters.
The Canadian cannabis retailer confirmed Tuesday that it had signed an agreement with the underwriters, by which they would purchase a total of 1.56 million units at a price of $9.60 per unit. In this way, High Tide will collect total gross proceeds in the amount of $15 million.
Under the offering, each unit will consist of one common share and one-half of one share purchase warrant of the company. Each warrant can be used to buy one share of the company in the following 36 months upon closing the offering at a price of $12.25 per warrant.
High Tide Inc. (TSXV: HITI) (OTCQB: HITIF) (FRA: 2LY) will raise $15 million via a bought deal public offering with ATB Capital Markets and Echelon Wealth Partners Inc. on behalf of a group of underwriters.
The Canadian cannabis retailer confirmed Tuesday that it had signed an agreement. Read More. Don t Miss Any Updates! News Directly in Your Inbox Subscribe to:
High Tide Inc. (TSXV: HITI) (OTCQB: HITIF) (FRA: 2LY) will raise $15 million via a bought deal public offering with ATB Capital Markets and Echelon Wealth Partners Inc. on behalf of a group of underwriters.
The Canadian cannabis retailer confirmed Tuesday that it had signed an agreement. Read More. Don t Miss Any Updates! News Directly in Your Inbox Subscribe to:
Article content
Ottawa, Ontario and Toronto, Ontario–(Newsfile Corp. – May 17, 2021) – HEXO Corp. (“HEXO”) (TSX: HEXO) (NYSE: HEXO) and 48North Cannabis Corp (“48North”) (TSXV: NRTH) are pleased to announce that they have entered into a definitive arrangement agreement (the “Arrangement Agreement”) under which HEXO will acquire, by way of court-approved plan of arrangement under the
Canada Business Corporations Act, all of 48North’s issued and outstanding common shares in an all-share transaction valued at approximately $50 million on an enterprise value basis (the “Transaction”).
We apologize, but this video has failed to load.
Try refreshing your browser. HEXO Corp to acquire 48North Cannabis Corp. Back to video